Patent details

Basic Information

Publication number:

EP3612176

PCT Application Number:

EP2018059969

Type:

European Patent Granted for LU

Legal Status:

Unitary Effect Registered

Application number:

EP187184627

PCT Publication Number:

WO2018193007

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION COMPRISING THE PPAR AGONIST ELAFIBRANOR AND AN ACETYL-COA CARBOXYLASE (ACC) INHIBITOR SELECTED FROM CP-640186, GEMCABENE, GS-0976 TO TREAT INFLAMMATORY, METABOLIC, FIBROTIC OR CHOLESTATIC DISEASES

French Title of Invention:

COMBINAISON COMPRENANT L'AGONISTE DU PPAR ELAFIBRANOR ET UN INHIBITEUR DE L'ACETYL-COA CARBOXYLASE (ACC) SÉLECTIONNÉ PARMI CP-640186, GEMCABENE, GS-0976 POUR TRAITER LES MALADIES INFLAMMATOIRES, MÉTABOLIQUES, FIBROTIQUES OU CHOLESTATIQUES

German Title of Invention:

KOMBINATION AUS DEM PPAR-AGONISTEN ELAFIBRANOR UND EINEM ACETYL-COA-CARBOXYLASE (ACC)-INHIBITOR, AUSGEWÄHLT AUS CP-640186, GEMCABENE, GS-0976, ZUR BEHANDLUNG VON ENTZÜNDLICHEN, METABOLISCHEN, FIBROTISCHEN ODER CHOLESTATISCHEN ERKRANKUNGEN

SPC Number:

Unitary Effect

Unitary Effect Requested:

Yes

Unitary Effect Request Filing Date:

01/10/2025

Link to UPP Register:

European Patent Register

Unitary Effect Request Withdrawal Date:

Unitary Effect Status:

Unitary Effect Registered

Unitary Effect Acceptance Decision Date:

13/10/2025

Unitary Effect Rejection Decision Date:

Unitary Effect Date:

17/09/2025

Unitary Effect Registration Date:

13/10/2025

Unitary Effect Re-establishment of rights Filing Date:

Unitary Effect Re-establishment of rights EPO Decision :

Unitary Effect Re-establishment of rights EPO Decision Date:

Explanatory Text UE:

Safety Net Request Date:

Safety Net Decision Date:

Safety Net Decision Outcome:

SPC Number:

Dates

Filing date:

18/04/2018

Grant date:

17/09/2025

EP Publication Date:

26/02/2020

PCT Publication Date:

25/10/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/09/2025

EP B1 Publication Date:

17/09/2025

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

18/04/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/09/2025

 

 

Name:

Genfit

Address:

885 avenue Eugène Avinée, 59120 Loos, France (FR)

Inventor

1

Name:

WALCZAK, Mathilde

Address:

France (FR)

2

Name:

WALCZAK, Robert

Address:

France (FR)

3

Name:

VIDAL, Guillaume

Address:

France (FR)

4

Name:

BELANGER, Carole

Address:

France (FR)

5

Name:

DESCAMPS, Emeline

Address:

France (FR)

6

Name:

LEGRY, Vanessa

Address:

France (FR)

7

Name:

DELBAERE, Isabelle

Address:

France (FR)

8

Name:

NOEL, Benoît

Address:

France (FR)

Priority

1

Priority Number:

17305452

Priority Date:

18/04/2017

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

18305150

Priority Date:

13/02/2018

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 31/192; A61K 31/194; A61K 31/5375; A61K 45/06; A61K 31/435; A61K 31/444; A61P 1/16; A61P 17/02; A61P 29/00; A61K 9/00; A61K 31/437; A61K 31/4439; A61K 31/519;

Publication

European Patent Bulletin

1

Issue number:

202538

Publication date:

17/09/2025

Description:

Grant (B1)

2

Issue number:

202545

Publication date:

05/11/2025

Description:

Unitary Effect Request Receipt

3

Issue number:

202546

Publication date:

12/11/2025

Description:

Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages